Cresp 40mcg Injection (Vial)

About

Cresp 40mcg Injection contains darbepoetin alfa, a synthetic form of erythropoietin, a hormone naturally produced by the kidneys that stimulates red blood cell production. This medication is designed to treat anemia by promoting the proliferation and differentiation of erythroid progenitor cells in the bone marrow. Its extended half-life compared to conventional erythropoietin allows for less frequent administration, improving patient convenience and adherence. Cresp is primarily indicated for the management of anemia associated with chronic kidney disease in both dialysis and non-dialysis patients, and for chemotherapy-induced anemia in cancer patients with non-myeloid malignancies. Regular monitoring of hemoglobin levels is essential to ensure optimal therapeutic response and minimize potential risks such as hypertension or thrombotic events.

Uses

• Treatment of anemia due to chronic kidney disease.
• Management of anemia in cancer patients undergoing chemotherapy.
• Reduction of the need for red blood cell transfusions.
• Alleviation of anemia-related symptoms like fatigue.

Directions For Use

Administer subcutaneously or intravenously as prescribed by a physician. Follow the specific dosage and schedule provided by your healthcare provider.

Benefits

• Effectively raises and maintains hemoglobin levels.
• Decreases the necessity for blood transfusions.
• Alleviates symptoms such as fatigue and weakness.
• Offers convenient, less frequent dosing schedule.
• Improves overall quality of life for anemic individuals.
• Stimulates the body's natural red blood cell production.

Side Effects

• High blood pressure
• Blood clot formation
• Headache
• Diarrhea
• Nausea
• Vomiting
• Fever
• Injection site pain
• Peripheral swelling
• Skin rash
• Cough
• Allergic reactions

Safety Measures

• Alcohol - No direct interaction, but excessive alcohol intake can impact overall health and kidney function, which may be relevant to the underlying condition.
• Pregnancy - Should only be used if the potential benefits justify the potential risks to the fetus. Consult your doctor.
• Breastfeeding - It is not known if darbepoetin alfa passes into breast milk. Use with caution and seek medical advice.
• Liver - Use with caution in patients with significant liver impairment; monitoring may be required.
• Kidney - Specifically indicated for anemia in chronic kidney disease. Dosage is adjusted based on kidney function and hemoglobin response.
• Lung - No specific contraindications, but monitor for signs of pulmonary embolism, especially in patients with pre-existing risk factors.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.